Press Releases

AMA applauds Supreme Court ruling preserving access to mifepristone

| 2 Min Read

The following statement is attributable to:
Bobby Mukkamala, MD
President-Elect, American Medical Association

Membership Moves Medicine™

  • Thousands of free CME opportunities to fulfill state requirements
  • A powerful voice fighting for you during uncertain times
  • Research, resources, events and more from the largest physician organization

“The American Medical Association applauds today’s unanimous ruling by the U.S. Supreme Court that preserves access to mifepristone for millions of women across the country.

“Efforts to second guess the FDA’s scientific judgment and roll back access to mifepristone were based on a sham case that not only lacked standing, but relied on speculative allegations and ideological assertions to undermine decades of rigorous scientific review proving the drug is highly safe and effective for both termination of pregnancy and for medical management of miscarriage.

“Substantial evidence shows that restricting access to needed abortion care without justification carries a psychological, physical, and economic toll. Current data show an association between restricted access to safe and legal abortion and higher rates of maternal morbidity and mortality, with already vulnerable populations experiencing the greatest burden.

“The AMA will continue to support access to safe and effective reproductive health care against the ongoing threats of interference in the practice of medicine.”


Editor’s Note:  For more information on AMA’s stand to preserve access to mifepristone, please see former statements, viewpoints, and the amicus brief filed with the US Supreme Court.

Statements
AMA opposes court ruling chipping away at mifepristone access - August 2023
Restored restrictions on mifepristone is a step backwards - April 2023
AMA: Texas mifepristone ruling flies in the face of science – April 2023
AMA applauds lifting restrictions on reproductive care medication – April 2021

Viewpoints
Reducing access to mifepristone would harm patients
Judge’s ruling on mifepristone has no basis in medical science

Amicus Brief

Alliance for Hippocratic Medicine v. FDA

Media Contact

AMA Media & Editorial

Phone: (312) 464-4430

[email protected]

About the American Medical Association

The American Medical Association is the physicians’ powerful ally in patient care. As the only medical association that convenes 190+ state and specialty medical societies and other critical stakeholders, the AMA represents physicians with a unified voice to all key players in health care.  The AMA leverages its strength by removing the obstacles that interfere with patient care, leading the charge to prevent chronic disease and confront public health crises and, driving the future of medicine to tackle the biggest challenges in health care.

FEATURED STORIES

Woman handing an insurance card to a doctor who is reviewing paperwork

AMA report: Health insurance giants tighten grip on U.S. markets

Dec 16, 2025
Patients in a waiting room at a doctor's office

What to expect from the 2026 Medicare Physician Fee Schedule

| 7 Min Read
Row of blocks with businesspeople with one being taken away

4 “Big, Beautiful Bill” changes that will reshape care in 2026

| 6 Min Read
Wood poles with question mark symbols

PAs push to enshrine “physician associate” term in law

| 6 Min Read